BERAND LIMITED

Berand Neuropharmacology is an independent pre‑clinical drug research company that delivers a full spectrum of in‑vivo neuropharmacology and pre‑clinical neurobiology services. Drawing on extensive resources and specialised expertise, the firm supports the research and development needs of global pharmaceutical and biotechnology organisations, helping them to translate early‑stage concepts into robust scientific data.

In addition to high‑value R&D service provision, Berand leverages its technical platforms to run in‑house drug‑discovery programmes focused on neurotherapeutic strategies for brain illnesses. This dual approach enables the company to offer both bespoke contract research and its own innovative pipeline, positioning it as a valuable partner for any entity seeking cutting‑edge insight into central nervous system targets.

Berand operates from the NovaUCD Belfield Innovation Park at University College Dublin, placing it at the heart of Ireland’s vibrant life‑science ecosystem while maintaining close links with international collaborators.